Key result
Novel vaccines for Foot-and-Mouth Disease offer potential advantages in safety and differentiation of infected from vaccinated animals, but require further development for practical application.
This review summarizes the latest research progress and future directions for novel Foot-and-Mouth Disease vaccines.
Requires further validation before veterinary use; leaves open optimized FMD vaccine platforms for future trials.
Foot-and-Mouth Disease (FMD), as a major global animal disease, affects millions of animals worldwide and remains the main sanitary barrier to the international and national trade of animals and animal products. Inactivated vaccination is the most effective measure for prevention of FMD at present, but fail to induce long-term protection and content new requires for production of FMD vaccines. As a number of Researchers hope to obtain satisfactory novel vaccines by new bio-technology, novel vaccines have been studied for more than thirty years. Here reviews the latest research progress of new vaccines, summarizes some importance and raises several suggestions for the future of FMD vaccine.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2011) conducted a review in Foot-and-Mouth Disease (FMD). Novel FMD vaccines vs. Traditional inactivated vaccines was evaluated. Novel vaccines for Foot-and-Mouth Disease offer potential advantages in safety and differentiation of infected from vaccinated animals, but require further development for practical application.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: